00000cam 2200000zi 4500 9.965451 CaOODSP 20260925105820 m o d f cr cn||||||||| 250826s2025 onca ob f000 0 eng d CaOODSP eng rda CaOODSP eng fre n-cn--- y1y2 H82-65/2025-PDF Gaudette, Étienne, 1953- author. Factors delaying the public listing of drugs in Canada / Étienne Gaudette, Shirin Rizzardo, Kevin R. Pothier, and Mina Tadrous = Facteurs retardant l'inscription dans les listes de médicaments de régimes publics au Canada / Étienne Gaudette, Shirin Rizzardo, Kevin R. Pothier et Mina Tadrous. Facteurs retardant l'inscription dans les listes de médicaments de régimes publics au Canada [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2025] 1 online resource (1 page) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier "NPDUIS, National Prescription Drug Utilization Information System." Includes bibliographical references. "The time to public listing for new drugs in Canada has been criticized, citing decentralized public payer structure and institutions leading to a prolonged listing process. We aim to identify and analyze key factors contributing to delays in the time-to-listing"--Objective. Text in English and French. Drug accessibility Canada. Drug approval Canada. Canada. Patented Medicine Prices Review Board, issuing body. Factors delaying the public listing of drugs in Canada / fre (CaOODSP)9.966263 PDF 1.54 MB https://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-65-2025.pdf HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/factors-delaying-2025poster.html